News
STOK
14.17
+37.71%
3.88
BUZZ-U.S. STOCKS ON THE MOVE-Netflix, Reddit, Stoke Therapeutics
The Dow Jones Industrial Average was up 0.72% on Wednesday. Merck & Co hit record high as FDA approves therapy for rare lung condition. Reddit Inc up 46% in fifth day of trading. Netflix, Reddit, Stoke Therapeutics are among the day's top stocks.
Reuters · 15h ago
SMR, GCTS and GSIW among mid-day movers
On the Move SMR, GCTS and GSIW among mid-day movers. GCT Semiconductor Holding (GCTS) and iBio are among the biggest gainers in the SA market. SMR and GCSR among the largest losers.
Seeking Alpha · 16h ago
12 Health Care Stocks Moving In Wednesday's Intraday Session
Stoke Therapeutics (NASDAQ:STOK) shares increased by 46.1% to $15.03 during Wednesday's regular session. The company's market cap stands at $671.1 million. Nutriband stock rose 24.33% as the company's Q4 earnings came out yesterday. Lixte Biotechnology and Ontrak also moved upwards.
Benzinga · 17h ago
BUZZ-U.S. STOCKS ON THE MOVE-Spirit Airlines, Cintas, Reddit
Dow Jones Industrial Average up 0.55% in thin trading ahead of long holiday weekend. Spirit Airlines, Cintas, Reddit among top gainers on Wall Street. U.S. Stock indexes rise ahead of crucial economic data and commentary from the Federal Reserve's policymakers.
Reuters · 17h ago
Stoke Therapeutics Shares Extend Gains to 52-Week High, Plans for $75M Offering
Stoke Therapeutics shares were up 48% to $15.19. The company said it's planning a proposed underwritten public offering to sell up to $75 million of shares. The stock hit its 52-week high of $16.40 earlier in the session. Stoke said data supports potential of its medicine to treat Dravet Syndrome.
Dow Jones · 18h ago
BUZZ-Stoke Therapeutics surges again after stock offering launch
Stoke Therapeutics' STOK.O up 45.8% at $15, highest since Nov 2022. Company announces $75 mln stock offering to fund development of product candidates. Company announced positive early-stage data for its epilepsy drug, STK-001.
Reuters · 18h ago
Stoke Therapeutics’ STK-001 Shows Promise: Buy Rating Affirmed Amid Positive Clinical and Financial Outlook
TipRanks · 1d ago
What's Going On With Stoke Therapeutics Stock Tuesday?
Stoke Therapeutics announced a proposed public offering of up to $75 million of its common stock after the bell on Tuesday. The company's shares are rising in Tuesday's after-hours session. Stoke Therapeutic shares surged more than 58% in regular session on the back of new data supporting potential for STK-001 in Dravet syndrome.
Benzinga · 1d ago
Stoke Therapeutics announces proposed public offering worth $75M
Stoke Therapeutics, Inc. Announces proposed public offering worth $75M. Stoke intends to use the net proceeds to fund research, clinical development and manufacturing of its product candidates. The company's stock is up 2.7% in pre-market trading on Tuesday.
Seeking Alpha · 1d ago
BRIEF-Stoke Therapeutics Announces Proposed Public Offering
Stoke Therapeutics Announces Proposed Public Offering of up to $75 million of its common stock. The company says it plans to offer the shares to the public in a public offering. Stoke Therapeutic Inc is a developer of a new drug for cancer.
Reuters · 1d ago
Crude Oil Moves Lower; TD SYNNEX Earnings Top Estimates
U.S. Stocks traded higher toward the end of trading on Tuesday, with the Dow Jones gaining over 80 points. The Dow traded up 0.21% to 39,397.20 while the NASDAQ rose 0.23%. TD SYNNEX Corporation reported better-than-expected first-quarter earnings. Consumer discretionary shares jumped by 0.6% on Monday. Asian markets closed mixed while European shares were higher today.
Benzinga · 1d ago
Stoke Therapeutics Up Over 65%, on Track for Record Percent Increase -- Data Talk
Stoke Therapeutics, Inc. ( STOK ) is currently at $10.74, up $4.24 or 65.23%. The stock is currently up four of the past five days. The company is up 38.76% month-to-date.
Dow Jones · 1d ago
BUZZ-U.S. STOCKS ON THE MOVE-Nuvation Bio, Seagate, AppFolio
Wall Street's main stock indexes climbed on Tuesday. Dow Jones Industrial Average was up 0.21% at 39,395.24. Most heavyweight growth stocks and chipmakers rose. Nuvation Bio, Seagate, AppFolio among the top percentage gainers.
Reuters · 1d ago
Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Westport Fuel Systems Inc. (NASDAQ:WPRT) posts wider-than-expected fourth-quarter loss. Krispy Kreme, Inc. And McDonald's expanded their partnership. Stoke Therapeutics, Inc., shares gained 72.6% to $11.24. C3is Inc. Reported a year-over-year increase in financial results.
Benzinga · 1d ago
12 Health Care Stocks Moving In Tuesday's Intraday Session
Stoke Therapeutics (NASDAQ:STOK) stock moved upwards by 71.8% to $11.16 during Tuesday's regular session. The company's, Q4 earnings came out 3 days ago. Mesoblast and OpGen shares also moved upwards.
Benzinga · 1d ago
Dow Gains 100 Points; McCormick Posts Upbeat Results
U.S. Stocks traded higher midway through trading on Tuesday, with the Dow Jones gaining around 100 points. The Dow traded up 0.25% to 39,413.30 while the NASDAQ rose 0.27%. McCormick & Co Inc reported better-than-expected first-quarter financial results. Consumer discretionary shares jumped by 0.8% on Monday. Asian markets closed mixed on Tuesday.
Benzinga · 1d ago
BUZZ-U.S. STOCKS ON THE MOVE-Reddit, CONSOL Energy, Nuvation Bio
Dow Jones Industrial Average was up 0.23% on Tuesday. Top three S&P 500 percentage gainers were Seagate Technology, Nuvation Bio and Krispy Kreme. Reddit, Consol Energy and Evercore are among the biggest decliners on the NYSE.
Reuters · 1d ago
Stocks Inch Higher After February's US Durable Goods Orders Released
NASDAQ · 1d ago
Stoke stock rockets 73% on updated epilepsy drug data
Stoke Therapeutics stock rockets 73% on updated epilepsy drug data. The company reported updated data from a Phase 1/2 study for its drug STK-001 in the treatment of children and adolescents with Dravet syndrome. Stoke stock shot up 73% in early trading Tuesday.
Seeking Alpha · 1d ago
Nasdaq Gains Over 50 Points; US Durable Goods Orders Rise In February
The Dow traded up 0.08% to 39,346.40 while the NASDAQ rose 0.39% on Tuesday. U.S. Durable goods orders increased by 1.4% month-over-month in February. Consumer discretionary shares jumped by 0.7% on Monday. Asian markets closed mixed in Asia Pacific markets.
Benzinga · 1d ago
More
Webull provides a variety of real-time STOK stock news. You can receive the latest news about Stoke Therapeutics through multiple platforms. This information may help you make smarter investment decisions.
About STOK
Stoke Therapeutics, Inc. is a biotechnology company focused on addressing the underlying causes of severe genetic diseases by upregulating protein expression with ribonucleic acid-based medicines. Using its Targeted Augmentation of Nuclear Gene Output (TANGO) approach, the Company is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its first compound, STK-001, is in clinical testing for the treatment of Dravet syndrome, a severe and progressive genetic epilepsy. STK-001 is designed to upregulate NaV1.1 protein expression by leveraging the non-mutant (wild-type) copy of the SCN1A gene to restore physiological NaV1.1 levels, thereby reducing both the occurrence of seizures and non-seizure comorbidities. Its STK-002 is a ASO in preclinical development for the treatment of Autosomal Dominant Optic Atrophy (ADOA). STK-002 is designed to upregulate OPA1 protein expression by leveraging the non-mutant (wild-type) copy of the OPA1 gene.